Gaudichaudione H Ameliorates Liver Fibrosis and Inflammation by Targeting NRF2 Signaling Pathway

Researchers underscored the potential therapeutic effect of Gaudichaudione H on alleviating hepatic fibrosis and inflammation through the augmentation of NRF2 signaling pathway, providing a promising avenue for the treatment of liver fibrosis and inflammation in clinical settings.